Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
J.E. Berchuck, Francesco Facchinetti, Daniel DiToro, et al.
Annals of Oncology (2022) Vol. 33, Iss. 12, pp. 1269-1283
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma
Lipika Goyal, Funda Meric‐Bernstam, Antoine Hollebecque, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 3, pp. 228-239
Open Access | Times Cited: 305
Cholangiocarcinoma — novel biological insights and therapeutic strategies
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 87
Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments
Marine Valéry, Damien Vasseur, Francesco Fachinetti, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4446-4446
Open Access | Times Cited: 24
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types
Pashtoon Murtaza Kasi, Jessica Lee, Lincoln W. Pasquina, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 836-848
Open Access | Times Cited: 22
Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA
Clémence Astier, Carine Ngo, Léo Colmet‐Daage, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe
Lorenza Rimassa, Ángela Lamarca, Grainne M. O’Kane, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101170-101170
Open Access | Times Cited: 1
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations
John Tyhonas, Lee D. Arnold, Jason M. Cox, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1734-1746
Closed Access | Times Cited: 7
The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples
Hongwei Peng, Ming Pan, Zongning Zhou, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 7
Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatments
Maurizio Capuozzo, Mariachiara Santorsola, Francesco Ferrara, et al.
Molecular and Cellular Probes (2024) Vol. 73, pp. 101951-101951
Open Access | Times Cited: 6
Understanding and Overcoming Resistance to Selective FGFR inhibitors Across FGFR2-Driven Malignancies
Francesco Facchinetti, Yohann Loriot, Floriane Brayé, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 21, pp. 4943-4956
Open Access | Times Cited: 6
Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer
Sohyun Hwang, Seonjeong Woo, Beodeul Kang, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 5
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102649-102649
Open Access | Times Cited: 14
Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper
Matteo Fassan, Valentina Angerilli, Nicola Normanno, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104224-104224
Open Access | Times Cited: 5
Clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling of patients with biliary tract cancer, especially with intrahepatic cholangiocarcinoma
Takafumi Yanaidani, Kazuo Hara, Nozomi Okuno, et al.
Clinical Endoscopy (2024) Vol. 57, Iss. 3, pp. 384-392
Open Access | Times Cited: 5
Clinical value of liquid biopsy in FGFR2 fusion-positive cholangiocarcinoma patients during targeted therapy
Alberto González‐Medina, María Vila-Casadesús, Marina Gómez-Rey, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 19, pp. 4491-4504
Open Access | Times Cited: 5
Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases
Raphael L. C. Araújo, Leonardo Gomes da Fonseca, Raphael Oliveira Silva, et al.
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 2, pp. 273-292
Open Access | Times Cited: 4
The Search for Risk, Diagnostic and Prognostic Biomarkers of Cholangiocarcinoma and their Biological and Clinicopathological Significance
Rocı́o I.R. Macı́as, Hiroaki Kanzaki, Carmen Berasain, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 4
Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders
Mao Yang, Yuhao Zhao, Chen Li, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 398-412.e4
Closed Access
Cholangiocarcinoma: The era of liquid biopsy
Evgenia Kotsifa, Francesca Saffioti, Vasileios Mavroeidis
World Journal of Gastroenterology (2025) Vol. 31, Iss. 11
Closed Access
Diagnostic accuracy of cfDNA levels in gallbladder cancer: A study using qPCR & threshold evaluation
Arpita Jindal, Sandeep Nijhawan, Urvashi Vijay, et al.
The Indian Journal of Medical Research (2025), pp. 1-9
Open Access
Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study
Yichen Zheng, Jiamin Guo, Tianhui Ren, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring
Woo Jin Choi, Tommy Ivanics, Annabel Gravely, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 6, pp. 3849-3863
Closed Access | Times Cited: 11
An overview of extrahepatic cholangiocarcinoma: from here to where?
Yongheng Yang, Xiaolu Zhang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
State of the Art: ctDNA in Upper Gastrointestinal Malignancies
Ibone Labiano, Ana E. Huerta, Virginia Arrazubi, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1379-1379
Open Access | Times Cited: 9
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma
Kristen Spencer, Leontios Pappas, Islam Baiev, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 7, pp. 870-880
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top